Liposarcoma future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Current clinical trials of liposarcoma are promising and genetic basis of the disease is studied extensively to find an effective treatment for this disease.

Tests and treatment go through four different phases of clinical trail to test the benefits of it. The four phases of treatment are as follows.^[1]

• Phase 1 trial

It aims to find out the best dose of a new drug with the lowest side effects

• Phase 2 trial

Asses whether a drug works for a specific cancer or not

• Phase 3 trial

Compares a new drug to a standard treatment

• Phase 4 trail

It involves drugs already approved by US FDA (Food and Drug administration) for atleast one disease.

Clinical trails are being conducted by SARC on soft tissue tumors as a part of furute investigationa therapies.^[2]

They work with the patient community to find the genetic markers of sarcoma. ^[3]

Template:WikiDoc Sources